期刊文献+

肝移植术后急性激素拮抗性排斥反应的诊治现状分析 被引量:4

Analysis of the diagnosis and treatment of acute steroid-resist-ant rejection after liver transplantation
原文传递
导出
摘要 肝移植术后急性激素拮抗性排斥反应(ASRR)的特点是患者对传统大剂量激素治疗反应差。目前认为抗体介导的排斥反应是发生ASRR的原因之一。报道显示多种抗排斥药物对其治疗有效,但目前尚无规范的治疗方案。本文系统回顾分析了ASRR的高危因素、发生机制、诊断标准和治疗策略。 The main feature of acute steroid-resistant rejection (ASRR) after liver transplantation is a lack of re- sponse to steroids. Although some effective immunosuppres- sants are available, there is no uniform treatment presently available. This paper will focus on exploring the mechanism of ASRR and formulating individually approached strategies.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第11期877-880,共4页 Chinese Journal of Hepatobiliary Surgery
基金 浙江省科技厅肝脏移植创新团队项目(2009R50038)
关键词 肝移植 急性激素拮抗性排斥反应 治疗 Liver transplantation Acute steroid-re-sistant rejections~ Diagnosis~ Treatment
  • 相关文献

参考文献3

二级参考文献24

  • 1马毅,朱晓峰,何晓顺,王国栋,王东平,胡红星,钱世鹍,胡安斌,鞠卫强,巫林伟.快速供肝切取与修整的外科技巧[J].中国实用外科杂志,2006,26(2):128-130. 被引量:37
  • 2Terasaki PI,Cai J.Humoral theory of transplantation:further evidence.Curr Opin Immunol 2005; 17:541-545.
  • 3Takemoto SK,Zeevi A,Feng S,Colvin RB,Jordan S,Kobashigawa J,Kupiec-Weglinski J,Matas A,Montgomery RA,Nickerson P,Platt JL,Rabb H,Thistlethwaite R,Tyan D,Delmonico FL.National conference to assess antibodymediated rejection in solid organ transplantation.Am J Transplant 2004; 4:1033-1041.
  • 4Takaya S,Iwaki Y,Starzl TE.Liver transplantation in positive cytotoxic crossmatch cases using FK506,high-dose steroids,and prostaglandin E1.Transplantation 1992; 54:927-929.
  • 5Ratner LE,Phelan D,Brunt EM,Mohanakumar T,Hanto DW.Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient.Transplantation 1993; 55:814-819.
  • 6Muro M,Marin L,Miras M,Moya-Quiles R,Minguela A,S(a)nchez-Bueno F,Bermejo J,Robles R,Ramirez P,Garcia-Alonso A,Parrilla P,Alvarez-L(o)pez MR.Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first yearafter transplantation:experience of one centre.Transpl Immunol 2005; 14:91-97.
  • 7Watson R,Kozlowski T,Nickeleit V,Woosley JT,Schmitz JL,Zacks SL,Fair JH,Gerber DA,Andreoni KA.Isolated donor specific alloantibody-mediated rejection after ABOcompatible liver transplantation.Am J Transplant 2006; 6:3022-3029.
  • 8Castillo-Rama M,Castro MJ,Bernardo I,Meneu-Diaz JC,Elola-Olaso AM,Calleja-Antolin SM,Romo E,Morales P,Moreno E,Paz-Artal E.Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival:role of human leukocyte antigen compatibility.Liver Transpl 2008; 14:554-562.
  • 9Rocha PN,Butterly DW,Greenberg A,Reddan DN,Tuttle-Newhall J,Collins BH,Kuo PC,Reinsmoen N,Fields T,Howell DN,Smith SR.Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.Transplantation 2003; 75:1490-1495.
  • 10White NB,Greenstein SM,Cantafio AW,Schechner R,Glicklich D,McDonough P,Pullman J,Mohandas K,Boctor F,Uehlinger J,Tellis V.Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.Transplantation 2004; 78:772-774.

共引文献13

同被引文献18

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部